ASCs should ‘look beyond the financial’ when considering private equity (Becker’s ASC Review)
ASCs can partner with private equity-backed platforms as a way to capitalize on future value and mitigate risks, but some ASC leaders warn that partnering with private equity firms requires consideration of costs outside the financial.
5 Key Diligence Considerations When Buying a GI Practice (JDSUPRA)
Private equity investors’ interest in gastroenterology (GI) practices continues to remain strong, despite some headwinds that GI practices have experienced as a result of the COVID-19 pandemic and further investment in this sector is likely to continue.
DiGI Capital Partners invests in stool AI company (AF21)
Over the course of five cycles, stool AI (stAI) was able to associate neural firing patterns with specific stool smells. It accurately detected eight of the smells 100% of the time, and remaining two with 90% accuracy.
Two GIs on the biggest threats to gastroenterology (Becker’s GI & Endoscopy)
Misunderstandings of Cologuard and shifts in reimbursement are some concerns gastroenterologists have for the field. Read to find out what the threats are.
CEO predicts Biden’s $1.9 trillion plan will help ASCs (Becker’s ASC Review)
Jason Richardson, CEO of Gastroenterology of the Rockies spoke about the influx of private equity in the ASC industry and how he thinks President Joe Biden’s $1.9 trillion COVID-19 relief law, dubbed the American Rescue Plan, could help ASC.
NYU Langone’s new grant seeks to address CRC disparities (Becker’s GI & Endoscopy)
New York City-based NYU Langone received a $2.2 million grant to expand a program addressing disparities in colorectal cancer and gastrointestinal health.
Gastroenterologists Routinely Reverse DNR Orders, Survey Finds (Gastroenterology & Endoscopy News)
Gastroenterologists reverse “do not resuscitate” orders to full code status more than 75% of the time prior to starting endoscopy, the results of a recent study show.
The smartest thing 7 ASC execs did last year (Becker’s ASC Review)
Last year the pandemic forced many ASCs to close or limit surgical volume, but enterprising administrators took the time as an opportunity to evaluate their growth strategy, improve culture, acquire new technology and become more efficient.
AI-powered imaging technique is pushing CRC risk management forward (Becker’s GI & Endoscopy)
A team at Washington University in St. Louis developed an imaging technique for rectal tissues to assess risk management of colorectal cancer. AR-PAM/US imaging was better at discerning residual cancer from scar tissue compared to other techniques.
Did the pandemic change ASC-hospital relationships? (Becker’s ASC Review)
ASCs and hospitals shared resources and collaborated on protocols for performing safe surgical procedures to ensure the continuity of care for patients who didn’t have COVID-19. But will the harmony last?
Reducing deaths from colorectal cancer (Kaiser Permanente)
Jeffrey K. Lee, MD, MAS, a research scientist at the Division of Research and a gastroenterologist with The Permanente Medical Group, spoke about colorectal cancer research and prevention.
